152 related articles for article (PubMed ID: 38399249)
1. Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis.
Alferiev IS; Zhang K; Folchman-Wagner Z; Adamo RF; Guerrero DT; Fishbein I; Soberman D; Levy RJ; Chorny M
Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399249
[TBL] [Abstract][Full Text] [Related]
2. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.
Chorny M; Fishbein I; Yellen BB; Alferiev IS; Bakay M; Ganta S; Adamo R; Amiji M; Friedman G; Levy RJ
Proc Natl Acad Sci U S A; 2010 May; 107(18):8346-51. PubMed ID: 20404175
[TBL] [Abstract][Full Text] [Related]
3. Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors.
Chorny M; Fishbein I; Tengood JE; Adamo RF; Alferiev IS; Levy RJ
FASEB J; 2013 Jun; 27(6):2198-206. PubMed ID: 23407712
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Nanoparticle-Mediated Targeting of Cell Therapy Reduces In-Stent Stenosis in Injured Arteries.
Polyak B; Medved M; Lazareva N; Steele L; Patel T; Rai A; Rotenberg MY; Wasko K; Kohut AR; Sensenig R; Friedman G
ACS Nano; 2016 Oct; 10(10):9559-9569. PubMed ID: 27622988
[TBL] [Abstract][Full Text] [Related]
5. Magnetically targeted delivery of therapeutic agents to injured blood vessels for prevention of in-stent restenosis.
Chorny M; Fishbein I; Adamo RF; Forbes SP; Folchman-Wagner Z; Alferiev IS
Methodist Debakey Cardiovasc J; 2012 Jan; 8(1):23-7. PubMed ID: 22891107
[TBL] [Abstract][Full Text] [Related]
6. Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries.
Banai S; Chorny M; Gertz SD; Fishbein I; Gao J; Perez L; Lazarovichi G; Gazit A; Levitzki A; Golomb G
Biomaterials; 2005 Feb; 26(4):451-61. PubMed ID: 15275819
[TBL] [Abstract][Full Text] [Related]
7. Magnetic nanoparticles for targeted vascular delivery.
Chorny M; Fishbein I; Forbes S; Alferiev I
IUBMB Life; 2011 Aug; 63(8):613-20. PubMed ID: 21721100
[TBL] [Abstract][Full Text] [Related]
8. Magnetically enhanced cell delivery for accelerating recovery of the endothelium in injured arteries.
Adamo RF; Fishbein I; Zhang K; Wen J; Levy RJ; Alferiev IS; Chorny M
J Control Release; 2016 Jan; 222():169-75. PubMed ID: 26704936
[TBL] [Abstract][Full Text] [Related]
9. Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system.
Battig MR; Fishbein I; Levy RJ; Alferiev IS; Guerrero D; Chorny M
Drug Deliv Transl Res; 2018 Aug; 8(4):954-963. PubMed ID: 28755158
[TBL] [Abstract][Full Text] [Related]
10. Computational Assessment of Unsteady Flow Effects on Magnetic Nanoparticle Targeting Efficiency in a Magnetic Stented Carotid Bifurcation Artery.
Hewlin RL; Smith M; Kizito JP
Cardiovasc Eng Technol; 2023 Oct; 14(5):694-712. PubMed ID: 37723333
[TBL] [Abstract][Full Text] [Related]
11. In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles.
Chan JM; Rhee JW; Drum CL; Bronson RT; Golomb G; Langer R; Farokhzad OC
Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19347-52. PubMed ID: 22087004
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of ultrasound-mediated therapeutic delivery of fibrin-targeted pioglitazone-loaded echogenic liposomes into the arterial bed for attenuation of peri-stent restenosis.
Klegerman ME; Moody MR; Huang SL; Peng T; Laing ST; Govindarajan V; Danila D; Tahanan A; Rahbar MH; Vela D; Genstler C; Haworth KJ; Holland CK; McPherson DD; Kee PH
J Drug Target; 2023 Jan; 31(1):109-118. PubMed ID: 35938912
[TBL] [Abstract][Full Text] [Related]
13. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
[TBL] [Abstract][Full Text] [Related]
14. Magnetically responsive paclitaxel-loaded biodegradable nanoparticles for treatment of vascular disease: preparation, characterization and in vitro evaluation of anti-proliferative potential.
Johnson B; Toland B; Chokshi R; Mochalin V; Koutzaki S; Polyak B
Curr Drug Deliv; 2010 Oct; 7(4):263-73. PubMed ID: 20695837
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus-loaded stealth colloidal systems attenuate neointimal hyperplasia after balloon injury: a comparison of phospholipid micelles and liposomes.
Haeri A; Sadeghian S; Rabbani S; Anvari MS; Lavasanifar A; Amini M; Dadashzadeh S
Int J Pharm; 2013 Oct; 455(1-2):320-30. PubMed ID: 23867987
[TBL] [Abstract][Full Text] [Related]
16. Impact of Fluoropolymer-Based Paclitaxel Delivery on Neointimal Proliferation and Vascular Healing: A Comparative Peripheral Drug-Eluting Stent Study in the Familial Hypercholesterolemic Swine Model of Femoral Restenosis.
Gasior P; Cheng Y; Valencia AF; McGregor J; Conditt GB; Kaluza GL; Granada JF
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28487355
[TBL] [Abstract][Full Text] [Related]
17. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.
Kayssi A; Al-Jundi W; Papia G; Kucey DS; Forbes T; Rajan DK; Neville R; Dueck AD
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012510. PubMed ID: 30684445
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
